Taking On Challenges And Growing? – Sunshine Biopharma Inc (SBFM)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Most recently, Yahoo Finance reported about the stock as it publicized that Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Stocks Info

This NASDAQ-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $0.08 and fluctuated between $0.0994 as its day high and $0.0775 as its day low. The current market capitalization of Sunshine Biopharma Inc is $8.14M. A total of 26.71 million shares were traded on the day, compared to an average of 20.73M shares.

In the most recent transaction, Slilaty Steve N. bought 100,000 shares of SBFM for 0.10 per share on Mar 04 ’24. After the transaction, the Chief Executive Officer now owns 130,000 company shares. In a previous transaction on Feb 08 ’24, Slilaty Steve N. bought 20,000 shares at 0.10 per share. SBFM shares that Chief Executive Officer owns now total 30,000.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, SBFM has a high of $1.40 and a low of $0.04.

As of this writing, SBFM has an earnings estimate of -$0.08 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$0.08 per share and a lower estimate of -$0.08. The company reported an EPS of -$0.04 in the last quarter, which was 33.30% higher than expectations of -$0.06.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. SBFM’s latest balance sheet shows that the firm has $2.05M in Cash & Short Term Investments as of fiscal 2021. There were $1.90M in debt and $91.23k in liabilities at the time. Its Book Value Per Share was $0.76, while its Total Shareholder’s Equity was $211.66k.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SBFM is Buy with a score of 5.00.

Most Popular

Related Posts